New York-based virtual women's health provider Maven Clinic is partnering with health-tracking ring maker Oura to allow Oura Ring wearers to sync their data with the Maven platform.. Maven Clinic is a ...

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as ...

Digital therapeutics company Big Health has been granted FDA 510(k) clearance for its SleepioRx digital therapeutic aimed at reducing insomnia and improving sleep.. The 90-day SleepioRX digital ...

Abridge, a generative AI platform for clinical conversations, has raised $300 million in Series E funding, bringing its valuation to a reported $5.3 billion. Andreessen Horowitz ( a16z) led the round ...

Population health technology company Color announced it had laid off workers as it pivots focus away from COVID-19 testing.. According to posts by former employees on LinkedIn, the company cut 300 ...

Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered workflows inside the Viz Oncology Suite. Viz.ai ...

The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.

Ellipsis Health, a company using AI voice agent technology, announced it has raised $45 million in a new Series A funding round. Salesforce, Khosla Ventures and CVS Health Ventures led the round.

Editor's note: This article has been updated with a comment from Hims & Hers CEO and the company. Pharma giant Novo Nordisk announced that it is terminating its contract with direct-to-consumer ...

Dr. Lukasz Kowalczyk, a physician at Colorado-based Peak Gastroenterology Associates, discusses the need for a multidisciplinary strategy for AI adoption - and building a clinically valuable algorithm ...

BrainCheck, a digital health company specializing in cognitive assessments, announced it secured $15 million in funding.. The investment was led by seed-stage investor Next Coast Ventures, venture ...

InSilicoTrials, a health tech company that develops AI-based simulation to predict drug safety and efficacy in the drug development process, announced it has been accepted into the Microsoft for ...